In combination or as monotherapy in the treatment of different cancer types (metastatic melanoma, metastatic renal cell carcinoma), anti-PD-1/PDL-1 drugs lead to pericarditis with an incidence of less than 1% (30). Here, PDCD1 is linked to cancer.